According to AgilePV’s research, Patient Support Programs account for between 25-40% of the adverse events collected by pharmaceutical companies every year. With case volumes expected to increase by 20% yearly, there has never been a better time to begin “eating the elephant” when it comes to automation.
Stop by our booth at World Drug Safety Conference's European meeting in Berlin! We'll be there showcasing our newest solutions and upgrades (not to mention our dazzling personalities).
Stop by our booth at DIA annual meeting! We'd love to show you what we're working on, and get your feedback!
How can you effectively track your RMPs across various products, markets and safety concerns and efficiently ensure compliance? The solution is simple: centralize and track your RMP activities with dedicated software which is accessible to local affiliates and provides global transparency and governance.
Are you in the American North East? Going to the World Drug Safety Conference Americas? Come check us out!
Join us in Glasgow, UK for the DIA 29th Annual Euromeeting! We'd love to chat about some new work we're doing to make Pharmacovigilance software forward looking. Have some interesting ideas for how to make PV software really match your needs? We want to hear them!
We will be discussing the state of the research for automatically tagging, categorizing, and determining an initial risk score for Adverse Events. We will also show you some new tools we are developing to do exactly that.
How can you effectively track your RMPs across various products, markets and safety concerns? Simple: centralize and track your RMP commitments with software which is accessible to local affiliates and provides global transparency and governance.
Join us in Washington, DC for the DIA Pharmacovigilance and Risk Management Strategies 2017! We'd love to chat about some new work we're doing to make Pharmacovigilance software finally forward looking. Have some interesting ideas for how to make PV software really match your needs? We want to hear them!
Capturing new Adverse Events is straightforward if they’re coming from structured sources, like standardized forms or external databases. Simple processes can be designed to look at this structured data and capture the AEs, even providing an initial risk determination.